Alkeon Capital Management Portfolio holdings
AUM
$20.6B
1-Year Return
8.97%
This Quarter Return
+0.2%
1 Year Return
+8.97%
3 Year Return
+43.14%
5 Year Return
+49.88%
10 Year Return
+256.15%
AUM
$15.8B
AUM Growth
-$903M
(-5.4%)
Cap. Flow
-$770M
Cap. Flow
% of AUM
-4.87%
Top 10 Holdings %
Top 10 Hldgs %
45.62%
Holding
110
New
4
Increased
22
Reduced
28
Closed
15
Top Buys
| 1 |
Dell
DELL
|
$208M |
| 2 |
KLA
KLAC
|
$183M |
| 3 |
Adobe
ADBE
|
$153M |
| 4 |
Amazon
AMZN
|
$137M |
| 5 |
Datadog
DDOG
|
$128M |
Top Sells
| 1 |
Alibaba
BABA
|
$204M |
| 2 |
Microsoft
MSFT
|
$174M |
| 3 |
Synopsys
SNPS
|
$160M |
| 4 |
Invesco QQQ Trust
QQQ
|
$157M |
| 5 |
BILL Holdings
BILL
|
$146M |
Sector Composition
| 1 | Technology | 38.52% |
| 2 | Communication Services | 22.93% |
| 3 | Consumer Discretionary | 17.24% |
| 4 | Financials | 8.32% |
| 5 | Healthcare | 3.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Yum! Brands
YUM
$39.7B
| $70.8M | 0.13% |
567,008
| – | – |
|
52
Ultragenyx Pharmaceutical
RARE
$3.02B
| $69.3M | 0.12% |
1,943,815
| – | – |
|
53
S&P Global
SPGI
$165B
| $62.1M | 0.11% |
169,892
| – | – |
|
54
XP
XP
$9.46B
| $60.3M | 0.11% |
2,617,617
| – | – |
|
55
JD.com
JD
$43.8B
| $59.1M | 0.11% |
2,027,555
-2,058,553
| -50% | -$60M |
|
56
Twilio
TWLO
$16.3B
| $58.5M | 0.1% |
1,000,000
-841,097
| -46% | -$49.2M |
|
57
Paylocity
PCTY
$9.72B
| $58M | 0.1% |
319,024
| – | – |
|
58
Sarepta Therapeutics
SRPT
$1.93B
| $55.6M | 0.1% |
458,845
-50,000
| -10% | -$6.06M |
|
|
SMAR
59
DELISTED
Smartsheet Inc.
SMAR
| $54.1M | 0.1% |
1,337,283
-909,000
| -40% | -$36.8M |
|
60
Keros Therapeutics
KROS
$628M
| $53.4M | 0.1% |
1,676,522
| – | – |
|
|
BPMC
61
DELISTED
Blueprint Medicines
BPMC
| $47.4M | 0.08% |
943,928
| – | – |
|
62
Rhythm Pharmaceuticals
RYTM
$6.87B
| $39.5M | 0.07% |
1,725,167
| – | – |
|
63
Marqeta
MQ
$2.76B
| $30.8M | 0.06% |
5,155,103
+2,500,000
| +94% | +$15M |
|
64
Cintas
CTAS
$83.1B
| $28.5M | 0.05% |
237,196
| – | – |
|
|
XYZ
65
Block, Inc.
XYZ
$46.2B
| $25.5M | 0.05% |
576,000
+176,000
| +44% | +$7.79M |
|
66
Oric Pharmaceuticals
ORIC
$1.03B
| $21M | 0.04% |
3,479,289
+500,000
| +17% | +$3.03M |
|
67
Xometry
XMTR
$2.5B
| $18.7M | 0.03% |
1,101,989
| – | – |
|
68
Stem
STEM
$118M
| $16.5M | 0.03% |
194,431
+50,000
| +35% | +$4.24M |
|
69
PMV Pharmaceuticals
PMVP
$76.8M
| $14.4M | 0.03% |
2,347,414
+867,547
| +59% | +$5.33M |
|
70
BioCryst Pharmaceuticals
BCRX
$1.73B
| $11.8M | 0.02% |
1,672,313
| – | – |
|
71
89bio
ETNB
$1.26B
| $10.8M | 0.02% |
700,000
| – | – |
|
|
KLRS
72
Kalaris Therapeutics, Inc. Common Stock
KLRS
$84.7M
| $9.9M | 0.02% |
200,222
| – | – |
|
73
Apple
AAPL
$3.53T
| $9.7M | 0.02% |
56,627
| – | – |
|
74
Caribou Biosciences
CRBU
$168M
| $7.86M | 0.01% |
1,644,863
+287,800
| +21% | +$1.38M |
|
|
MREO
75
Mereo BioPharma
MREO
$270M
| $4.82M | 0.01% |
3,738,100
| – | – |
|